insights_auto
Why is ZTS up 2,37%?
Dive Deeperchevron_right
ZTS:NYSE
Zoetis Inc
74,81 USD
arrow_upward
+2,37%(+1,73) 1D
73,90 USD
arrow_downward
-1,21% (-0,91)bedtimeAfter hours
Closed: 9-окт., 16:03:16 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZTS...
Open
73,04 USD
High
74,85 USD
Low
73,00 USD
Mkt. cap
30,91 млд
Avg. vol.
4,59 млн
Volume
2,91 млн
Dividend
2,83%
Quarterly dividend
0,53 USD
Ex-dividend date
2026-ж., 20-июл.
P/E ratio
12,31
52-wk high
148,30 USD
52-wk low
68,77 USD
EPS
6,08 USD
Beta
0,74
Shares outstanding
413,22 млн
No. of employees
14 миң
Open
73,04 USD
High
74,85 USD
Low
73,00 USD
Mkt. cap
30,91 млд
Avg. vol.
4,59 млн
Volume
2,91 млн
Dividend
2,83%
Quarterly dividend
0,53 USD
Ex-dividend date
2026-ж., 20-июл.
P/E ratio
12,31
52-wk high
148,30 USD
52-wk low
68,77 USD
EPS
6,08 USD
Beta
0,74
Shares outstanding
413,22 млн
No. of employees
14 миң
News stories
From web sources and news partners
Zacks
·
17 саат мурун
Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know
Yahoo Finance
·
18 саат мурун
Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know
Benzinga
·
22 саат мурун
10 Health Care Stocks Whale Activity In Today’s Session
Investing.com
·
1 күн мурун
Zoetis declares $0.53 quarterly dividend, payable December 1
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14,5 миң
Founded1952
HeadquartersParsippany-Troy Hills, Нью Джерси, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websitezoetis.com